{"schema_version":"secwatch.filing_event.v1","accession":"0001932393-24-000015","form_type":"8-K/A","ticker":"GEHC","cik":"0001932393","company_name":"GE HealthCare Technologies Inc.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.331360+00:00","generated_at":"2026-06-06T08:35:53.808170+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"GE HealthCare Q4 revenue $5.2B (+5% organic); FY24 guided adj EPS $4.20-$4.35","bullets":["Q4 revenue $5.2B (+5% organic YoY); net income $403M, adj EPS $1.18; adj EBIT margin 16.1%.","Full-year 2023 revenue $19.6B (+8% organic); adj EPS $3.93; operating cash flow $2.1B.","Segment: Imaging +4%, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23% organic.","FY2024 guidance: organic rev growth ~4%; adj EBIT margin 15.6%-15.9%; adj EPS $4.20-$4.35; FCF ~$1.8B.","Repaid $850M debt in Q4 and $150M in Jan 2024; announced agreement to acquire MIM Software (no terms disclosed)."],"urls":{"canonical":"https://secwatch.observer/filing/0001932393-24-000015","json":"https://secwatch.observer/filing/0001932393-24-000015.json","markdown":"https://secwatch.observer/filing/0001932393-24-000015.md","text":"https://secwatch.observer/filing/0001932393-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000015/0001932393-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000015/gehc-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:35:53.808170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34831d0306dc15b889695459833ed082690b4e08","claim":"GE HealthCare Technologies Inc. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $5.2 billion, net income $403 million. Guidance initiated.","evidence_excerpt":"growth. We’re confident heading into 2024 amid the backdrop of an improved capital equipment landscape.” Fourth Quarter 2023 Total Company Financial Performance • Revenues of $5.2 billion increased 5% on both a reported and Organic* basis year-over-year, driven by price and volume. • Total company book-to-bill was strong at 1.05 times, defined as Total orders","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000015/0001932393-24-000015-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$5.2 billion"},{"label":"Net income","value":"$403 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}